Literature DB >> 16002660

Active Ca2+/calmodulin-dependent protein kinase II gamma B impairs positive selection of T cells by modulating TCR signaling.

Maureen A McGargill1, Leslie L Sharp, Jack D Bui, Stephen M Hedrick, Sébastien Calbo.   

Abstract

T cell development is regulated at two critical checkpoints that involve signaling events through the TCR. These signals are propagated by kinases of the Src and Syk families, which activate several adaptor molecules to trigger Ca(2+) release and, in turn, Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) activation. In this study, we show that a constitutively active form of CaMKII antagonizes TCR signaling and impairs positive selection of thymocytes in mice. Following TCR engagement, active CaMKII decreases TCR-mediated CD3zeta chain phosphorylation and ZAP70 recruitment, preventing further downstream events. Therefore, we propose that CaMKII belongs to a negative-feedback loop that modulates the strength of the TCR signal through the tyrosine phosphatase Src homology 2 domain-containing phosphatase 2 (SHP-2).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002660     DOI: 10.4049/jimmunol.175.2.656

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Role of TRP ion channels in cancer and tumorigenesis.

Authors:  George Shapovalov; Abigael Ritaine; Roman Skryma; Natalia Prevarskaya
Journal:  Semin Immunopathol       Date:  2016-02-03       Impact factor: 9.623

Review 2.  The regulation of dendritic cell function by calcium-signaling and its inhibition by microbial pathogens.

Authors:  S F Connolly; D J Kusner
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

3.  Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca²⁺/calmodulin-dependent protein kinase II.

Authors:  Zhipeng Meng; Tao Li; Xiaoxiao Ma; Xiaoqiong Wang; Carl Van Ness; Yichao Gan; Hong Zhou; Jinfen Tang; Guiyu Lou; Yafan Wang; Jun Wu; Yun Yen; Rongzhen Xu; Wendong Huang
Journal:  Mol Cancer Ther       Date:  2013-08-19       Impact factor: 6.261

4.  CaMK-II promotes focal adhesion turnover and cell motility by inducing tyrosine dephosphorylation of FAK and paxillin.

Authors:  Charles A Easley; Claire M Brown; Alan F Horwitz; Robert M Tombes
Journal:  Cell Motil Cytoskeleton       Date:  2008-08

5.  Genomic expression profiling of TNF-alpha-treated BDC2.5 diabetogenic CD4+ T cells.

Authors:  Li-Fen Lee; Chih-Jian Lih; Chao-Jen Huang; Thai Cao; Stanley N Cohen; Hugh O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-15       Impact factor: 11.205

6.  Calcium/calmodulin-dependent protein kinase IV signaling pathway is upregulated in experimental necrotizing enterocolitis.

Authors:  Mashriq Alganabi; Haitao Zhu; Joshua S O'Connell; George Biouss; Andrea Zito; Bo Li; Edoardo Bindi; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2020-01-16       Impact factor: 1.827

7.  Predikin and PredikinDB: a computational framework for the prediction of protein kinase peptide specificity and an associated database of phosphorylation sites.

Authors:  Neil F W Saunders; Ross I Brinkworth; Thomas Huber; Bruce E Kemp; Bostjan Kobe
Journal:  BMC Bioinformatics       Date:  2008-05-26       Impact factor: 3.169

Review 8.  Modeling CaMKII in cardiac physiology: from molecule to tissue.

Authors:  Birce Onal; Sathya D Unudurthi; Thomas J Hund
Journal:  Front Pharmacol       Date:  2014-02-04       Impact factor: 5.810

Review 9.  Molecular biomarkers in cardiac hypertrophy.

Authors:  Liu Zhu; Chao Li; Qiang Liu; Weiting Xu; Xiang Zhou
Journal:  J Cell Mol Med       Date:  2019-01-16       Impact factor: 5.310

10.  In vitro and in vivo study on prevention of myocardial ischemic injury by taurine.

Authors:  Fengyun Ren; Xing Liu; Xiaoxue Liu; Yanli Cao; Lantao Liu; Xingjiang Li; Yingjun Wu; Shudi Du; Guozhong Tian; Jing Hu
Journal:  Ann Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.